BioCentury
ARTICLE | Financial News

Selecta prices $70M IPO

June 22, 2016 11:53 PM UTC

Immunomodulatory company Selecta Biosciences Inc. (NASDAQ:SELB) was unchanged its first day of trading Wednesday after raising $70 million through the sale of 5 million shares at $14 in an IPO. The price valued Selecta at $247.3 million.

The company filed in May to raise up to $75 million. Earlier this month, Selecta said it hoped to sell 4.3 million shares at $14-$16. UBS, Stifel, Canaccord and Needham are underwriters. ...